NO.1 MEDICAL CODING INSTITUTE IN CALICUT

 A83.2 

(EASTERN EQUINE ENCEPHALITIS)







                               Eastern equine encephalitis (EEE) is an extremely rare but serious and often fatal infection that causes encephalitis or inflammation of the brain. It is spread by the bite of a mosquito infected with EEE virus (EEEV). EEEV can also infect a wide range of animals including mammals, birds, reptiles, and amphibians. Signs and symptoms of neurologic disease include fever, headache, vomiting, diarrhea, seizures, behavioral changes, drowsiness, and coma. In infants, neurologic disease often occurs soon after onset; in older children and adults, encephalitis may occur after several days of systemic illness.
 
                                       There is no specific treatment for EEE. Antibiotics are not effective against viruses, and no effective anti-viral drugs have been discovered. Severe illnesses are treated by supportive therapy which may include hospitalization, respiratory support, IV fluids, and prevention of other infections.

SYMPTOMS

  • high fever.
  • headache.
  • tiredness.
  • nausea/vomiting.
  • neck stiffness.

The severity of viral encephalitis depends on the particular virus and how quickly treatment was given. Generally, the acute phase of the illness lasts around one or two weeks, and the symptoms either disappear quickly or subside slowly over a period of time. In many cases, the person makes a full recovery. In mild cases of encephalitis, the inflammation will likely resolve in a few days. For people who have severe cases it may require weeks or months for them to get better. It can sometimes cause permanent brain damage or even death. 

How is encephalitis treated?

  • rest
  • pain killers
  • corticosteroids (to reduce brain inflammation)
  • mechanical ventilation (to help with breathing)
  • lukewarm sponge baths
  • anticonvulsants (to prevent or stop seizures)
  • sedatives (for restlessness, aggressiveness, and irritability)
  • fluids (sometimes through an IV)
  • E83.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2021 edition of ICD-10-CM E83.2 became effective on October 1, 2020.
  • This is the American ICD-10-CM version of E83.2 - other international versions of ICD-10 E83.2 may differ.
Applicable To
  • Acrodermatitis enteropathica
The following code(s) above E83.2 contain annotation back-references
 that may be applicable to E83.2:
  • E00-E89 
     Endocrine, nutritional and metabolic diseases
  • E70-E88 
     Metabolic disorders
  • E83 
     Disorders of mineral metabolism
Approximate Synonyms
  • Disorder of zinc metabolism
  • Zinc metabolism disorder
Clinical Information
  • Severe human skin and gastrointestinal disease inherited as a recessive autosomal trait that is characterized by the symptoms of zinc deficiency and clears up when zinc is added to the diet.
ICD-10-CM E83.2 is grouped within Diagnostic Related Group(s) (MS-DRG v38.0):
  • 602 Cellulitis with mcc
  • 603 Cellulitis without mcc

Convert E83.2 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
Code annotations containing back-references to E83.2:
  • Type 1 Excludes: Q82
Diagnosis Index entries containing back-references to E83.2:
  • Acrodermatitis L30.8
    • enteropathica E83.2 (hereditary)
  • Brandt's syndrome E83.2 (acrodermatitis enteropathica)
  • Danbolt E83.2 (-Cross) syndrome (acrodermatitis enteropathica)
  • Disorder (of) - see also Disease
  • Syndrome - see also Disease
    • Brandt's E83.2 (acrodermatitis enteropathica)
    • Danbolt E83.2 (-Cross) (acrodermatitis enteropathica)
  • Zinc
    • metabolism disorder E83.2

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Comments